Cancer Letters

Cancer Letters

Volume 344, Issue 2, 28 March 2014, Pages 166-173
Cancer Letters

Mini-review
MiR-200, a new star miRNA in human cancer

https://doi.org/10.1016/j.canlet.2013.11.004Get rights and content

Abstract

MicroRNAs (miRNAs) are a set of non-coding small RNA molecules in control of gene expression at posttranscriptional/translational level. They not only play crucial roles in normal developmental progress, but also are commonly dysregulated in human diseases, including cancer. MiR-200 is a family of tumor suppressor miRNAs consisting of five members, which are significantly involved in inhibition of epithelial-to-mesenchymal transition (EMT), repression of cancer stem cells (CSCs) self-renewal and differentiation, modulation of cell division and apoptosis, and reversal of chemoresistance. In this article, we summarize the latest findings with regard to the tumor suppressor signatures of miR-200 and the regulatory mechanisms of miR-200 expression. The collected evidence supports that miR-200 is becoming a new star miRNA in study of human cancer.

Introduction

MicroRNAs (miRNAs) are a class of short non-coding RNA molecules with a significant regulatory capacity on gene expression [1], [2]. Similar to protein-coding genes, the primary transcripts of miRNA (pri-miRNA) are derived from genomic DNA and synthesized by RNA polymerase II or III into a hairpin structure [3], [4]. After being further processed by the RNase III family enzymes, Drosha and DiGeorge syndrome critical region gene 8 (DGCR8), the excess nucleotides at both the 3′ and 5′ regions of pri-miRNA are cropped off to form precursor miRNA (pre-miRNA) that is ∼70 nt in length [5], [6], [7], [8]. Then, pre-miRNA will be exported out of the nucleus by the double-stranded RNA binding protein Exportin-5, and this intermediate product is subsequently cleaved by the RNase III family enzyme, Dicer, into imperfect mature miRNA:miRNA∗duplexes in the cytoplasm [9], [10], [11], [12], [13]. The miRNA strand of approximately 18–22 nucleotides is incorporated into the RNA-induced silencing complex (RISC), which guides mature miRNA to trigger the target mRNA for subsequent silencing [14], [15]. Although the extent to which miRNAs regulate the human transcriptome is still under investigation, more and more evidence supports the fact that miRNA plays a crucial regulatory role in the control of gene expression.

To date, a total of 2578 mature miRNA sequences have been identified in humans in accordance to the latest release of the miRBase database (http://www.mirbase.org/). The miRNA-200 family consisting of five members (miR-200a, miR-200b, miR-200c, miR-429, and miR-141), is of particular interest for human health and disease. Based on the chromosomal locations, the miR-200 family can be divided into two clusters: the miR-200ba/429 cluster containing miR-200a, miR-200b, and miR-429, which is located on chromosome 1p36, and the miR-200c/141 cluster, which contains miR-200c and miR-141 and is located on chromosome 12p13. As known, in miRNA biology, seed sequences, in terms of the complementary sequences to binding sites of miRNA within the 3′ untranslated regions (UTRs) of the target genes, play a crucial role in regulatory effects of miRNA on gene expression [16]. Theoretically speaking, the members of a miRNA family contain highly conservative seed sequences; and miRNAs with the identical seed sequences may share the same putative target gene profiles. For the miR-200 family, two types of seed sequences are identified, which only have a nucleotide difference. MiR-200b, miR-200c, and miR-429 contain AAUACUG, whereas miR-200a and miR-141 possess AACACUG as their seed sequences. For the convenience of functional analysis, some studies named the miR-200bc/429 and miR-200a/141 clusters based on the seed sequences and potential similar target gene profiles [17], which are distinct from miR-200ba/429 and miR-200c/141 that are defined based on the chromosomal locations.

The first correlative report showing a relationship between the miR-200 family and human health demonstrated its high olfactory enrichment and neural expression patterns, consistent with a role in olfactory neurogenesis [18]. Soon afterwards, its involvement in human disease was confirmed when new studies demonstrated that miR-200 appeared to be downregulated during tumor progression and acted as a key inhibitor for epithelial-to-mesenchymal transition (EMT), tumor cell invasion, and metastasis. These benchmark results have been summarized in several high quality reviews [19], [20], [21], [22], [23], [24]. To be complementary to these articles, we focus on presentation of the latest findings on studies of miR-200 tumor suppressive roles in human cancer, which include inhibition of EMT, repression of cancer stem cell (CSC) self-renewal and differentiation, modulation of cell division and apoptosis, and involvement in chemoresistance. Moreover, after sorting out many related publications, we summarize the mechanisms accounting for the regulation of miR-200 expression in various cancer cells. These results have not yet been collated to date but will be of importance to understand the tumor suppressor role of miR-200 in human cancer. We hope that this review article can provide useful insights into translation of the achievements gained from miRNA research into the future clinical applications.

Section snippets

Inhibition of epithelial mesenchymal transition (EMT) and tumor metastasis

The involvement of miR-200 in cancer originates from several studies demonstrating a significant role for miR-200 in EMT, which is an important process in tumor progression as well as embryonic development. The expression of miR-200 family members was found to be highly associated with the epithelial phenotype of cancer cells, serving as a class of key markers for E-cadherin-positive and vimentin-negative cancer cell lines [25], [26], [27]. ZEB1 and ZEB2 are two members of the zinc-finger E-box

Regulation of miR-200 expression

Given that miRNA is a class of non-coding small RNA molecules, the transcription factor involved regulation and epigenetic modulation are two major mechanisms that control miRNA expression. Due to the increased interest in miR-200 as well as its tumor suppressor role in a variety of human tumors, better understanding of miR-200 regulatory mechanisms can provide insights into the future translation of miR-200’s tumor suppressive signatures into development of novel strategies for treating human

Conclusion and perspective

The inhibitory effect of miR-200 on EMT by targeting ZEBs is the benchmark achievement to understand the tumor suppressor roles of miR-200 in human cancer. As discussed earlier, the promoter regions of both miR-200 clusters have binding sites for ZEB1 and ZEB2 transcription factors. Interestingly, both ZEBs can be targeted by miR-200, reciprocally, hinting at a possible unknown mechanism by which a feedback inhibition loop can be broken and cells can be switched between an epithelial and

Conflict of Interest

We disclose that we do not have any conflicts of interest.

Acknowledgements

This study is supported by the American Cancer Society Research Scholar Grant (RSG-13-265-01-RMC, to Xi) and the NIH/NCI R21 Grant (5R21CA160280, to Xi). We sincerely apologize to those whose work was not cited due to time and space constraints.

References (107)

  • X. Hu et al.

    A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer

    Gynecol. Oncol.

    (2009)
  • N. Zidar et al.

    Down-regulation of microRNAs of the miR-200 family and miR-205, and an altered expression of classic and desmosomal cadherins in spindle cell carcinoma of the head and neck–hallmark of epithelial–mesenchymal transition

    Hum. Pathol.

    (2011)
  • J. Chen et al.

    Overexpression of miR-429 induces mesenchymal-to-epithelial transition (MET) in metastatic ovarian cancer cells

    Gynecol. Oncol.

    (2011)
  • Y. Shimono et al.

    Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells

    Cell

    (2009)
  • D. Iliopoulos et al.

    Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells

    Mol. Cell

    (2010)
  • P. Samavarchi-Tehrani et al.

    Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming

    Cell Stem Cell

    (2010)
  • R. Schickel et al.

    MiR-200c regulates induction of apoptosis through CD95 by targeting FAP-1

    Mol. Cell

    (2010)
  • F. Meng et al.

    Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines

    Gastroenterology

    (2006)
  • Y. Lee et al.

    MicroRNA genes are transcribed by RNA polymerase II

    EMBO J.

    (2004)
  • G.M. Borchert et al.

    RNA polymerase III transcribes human microRNAs

    Natl. Struct. Mol. Biol.

    (2006)
  • Y. Lee et al.

    The nuclear RNase III Drosha initiates microRNA processing

    Nature

    (2003)
  • E. Lund et al.

    Nuclear export of microRNA precursors

    Science

    (2004)
  • R. Yi et al.

    Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs

    Genes Dev.

    (2003)
  • M.T. Bohnsack et al.

    Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs

    RNA

    (2004)
  • E. Bernstein et al.

    Role for a bidentate ribonuclease in the initiation step of RNA interference

    Nature

    (2001)
  • G. Hutvagner et al.

    A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA

    Science

    (2001)
  • R.F. Ketting et al.

    Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans

    Genes Dev.

    (2001)
  • S.W. Knight et al.

    A role for the RNase III enzyme DCR-1 in RNA interference and germ line development in Caenorhabditis elegans

    Science

    (2001)
  • Z. Mourelatos et al.

    MiRNPs: a novel class of ribonucleoproteins containing numerous microRNAs

    Genes Dev.

    (2002)
  • M.A. Valencia-Sanchez et al.

    Control of translation and mRNA degradation by miRNAs and siRNAs

    Genes Dev.

    (2006)
  • S. Uhlmann et al.

    MiR-200bc/429 cluster targets PLCgamma1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer

    Oncogene

    (2010)
  • P.A. Gregory et al.

    MicroRNAs as regulators of epithelial–mesenchymal transition

    Cell Cycle

    (2008)
  • M. Korpal et al.

    The emerging role of miR-200 family of microRNAs in epithelial–mesenchymal transition and cancer metastasis

    RNA Biol.

    (2008)
  • P.S. Mongroo et al.

    The role of the miR-200 family in epithelial–mesenchymal transition

    Cancer Biol. Ther.

    (2010)
  • S. Brabletz et al.

    The ZEB/miR-200 feedback loop – a motor of cellular plasticity in development and cancer?

    EMBO Rep.

    (2010)
  • L. Hill et al.

    ZEB/miR-200 feedback loop: at the crossroads of signal transduction in cancer

    Int. J. Cancer

    (2013)
  • S.M. Park et al.

    The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2

    Genes Dev.

    (2008)
  • P.A. Gregory et al.

    The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

    Natl. Cell Biol.

    (2008)
  • G. Browne et al.

    ZEB proteins link cell motility with cell cycle control and cell survival in cancer

    Cell Cycle

    (2010)
  • E.D. Wiklund et al.

    Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer

    Int. J. Cancer

    (2011)
  • E. Aydogdu et al.

    MicroRNA-regulated gene networks during mammary cell differentiation are associated with breast cancer

    Carcinogenesis

    (2012)
  • M.A. Castilla et al.

    MicroRNA-200 family modulation in distinct breast cancer phenotypes

    PLoS One

    (2012)
  • K.H. Gravgaard et al.

    The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancer

    Breast Cancer Res. Treat

    (2012)
  • K. Hur et al.

    MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis

    Gut

    (2013)
  • E.L. Paterson et al.

    Down-regulation of the miRNA-200 family at the invasive front of colorectal cancers with degraded basement membrane indicates EMT is involved in cancer progression

    Neoplasia

    (2013)
  • L.C. van Kempen et al.

    Loss of microRNA-200a and c, and microRNA-203 expression at the invasive front of primary cutaneous melanoma is associated with increased thickness and disease progression

    Virchows Arch.

    (2012)
  • J. Snowdon et al.

    The microRNA-200 family is upregulated in endometrial carcinoma

    PLoS One

    (2011)
  • Y. Du et al.

    Down-regulation of miR-141 in gastric cancer and its involvement in cell growth

    J. Gastroenterol

    (2009)
  • J. Kurashige et al.

    MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma

    Ann. Surg. Oncol.

    (2012)
  • A. Shinozaki et al.

    Downregulation of microRNA-200 in EBV-associated gastric carcinoma

    Cancer Res.

    (2010)
  • Cited by (302)

    • Epigenetic control of cell signalling in cancer stem cells

      2024, International Review of Cell and Molecular Biology
    View all citing articles on Scopus
    View full text